Introduction
In recent years, interest in mechanosensitive ion channels has been growing. In these ion channels, transient receptor potential vanilloid 4 (TRPV4) is recognized as an osmoreceptor [O'Neil and Heller, 2005] . TRPV4, a member of the transient receptor potential superfamily, is a Ca 2+ permeable nonselective cationic channel that is Expression of the Cationic Channel TRPV4 in the Endolymphatic Sac Audiol Neurotol 2009; 14:190-197 191 In general, when cells swell due to osmosis in a hypotonic condition, they recover their original volume in the continued presence of the osmotic stress by an active reduction of cell volume, which is called regulatory volume decrease [Lang et al., 1998 ]. It has been proven that TRPV4 controls regulatory volume decrease in airway epithelial cells [Arniges et al., 2004] and keratinocyte cell lines [Becker et al., 2005] . Thus, to investigate whether TRPV4 controls regulatory volume decrease in the endolymphatic sac, we conducted cell volume measurements using tissues cultured from rat endolymphatic sacs. After these experiments in the rat endolymphatic sac, expression patterns of TRPV4 were also investigated by immunohistochemistry in human endolymphatic sacs obtained from patients with vestibular schwannoma and Ménière's disease. The data presented here demonstrate a novel association between TRPV4 and the endolymphatic sac.
Materials and Methods

Tissue Culture of the Endolymphatic Sac
Rats (at postnatal day 4) were anesthetized by sodium pentobarbital (0.4 mg/g body mass) and then decapitated. Temporal bones were removed immediately and placed in cold (4 ° C) HEPESbuffered saline with Hanks' balanced salt solution (138 m M NaCl, 5 m M KCl, 0.5 m M MgCl 2 , 1.3 m M CaCl 2 , 5 m M glucose, 10 m M HEPES, pH 7.2). The entire endolymphatic sac was removed from the temporal bone, opened at the edge of the distal portion of the endolymphatic sac and mounted flat on a culture slide that was coated with 20 l Cell Tek (Becton Dickinson Labware, USA) diluted 1: 5 and covered with 300 l culture medium consisting of minimum essential medium with D -valine to suppress fibroblast growth, supplemented with 10% fetal calf serum, 10 m M HEPES, 100 IU/ml penicillin and 2 m M glutamine. Cultures were kept in a 5% CO 2 atmosphere at 37 ° C for up to 2 days. The morphology of the culture was monitored by differential interference contrast infrared light microscopy. Detailed surface morphology of the epithelia was obtained by scanning electron microscopy. The coverslips with the explants were fixed with a 2.5% glutaraldehyde, 0.1 M sodium cacodylate buffer for 120 min and postfixed in 1% osmium tetroxide for 60 min. Then they were washed, dehydrated, gold-coated according to the standard procedures and examined using a Hitachi 500 scanning electron microscope.
Immunostaining Procedure for the Rat Endolymphatic Sac
Cells grown on glass coverslips were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 20 min. The cells were washed in PBS and permeabilized with 0.1% Triton X-100 in PBS for 3 min. The specimens were incubated overnight in a humidified chamber at 4 ° C with a rabbit polyclonal antibody to TRPV4 (Alomone Labs Ltd., Jerusalem, Israel) at a dilution of 1: 200 in PBS. The TRPV4 antibody was originally raised against a synthetic peptide representing the carboxyl-terminal sequence of TRPV4, and it was then subjected to affinity purification with the peptide antigen (CDG HQQ GYA PKW RTD DAP L). Specimens were then incubated with anti-rabbit Cy3-conjugated secondary antibody (Dianova, Japan) for 1 h, washed and mounted. Then, immunostained specimens were analyzed with a confocal laser microscope (LSM 510, Zeiss, Germany). Images were digitally captured and then analyzed using the imaging software provided and downloaded from Zeiss. Control samples consisted of rat kidney tissue known to contain TRPV4. Technique controls were performed for each specimen using the same method but omitting the use of the primary antibody.
Measurement of Cell Volume
Cells were loaded with the fluorescent probe calcein (Molecular Probes, Japan), and were excited at 490 nm. Emitted fluorescence was measured at 510 nm. Prior to each experiment, initial fluorescence changes under isotonic conditions were recorded and later used to calculate fluorescence drift correction. Fluorescence intensity changes induced by anisosmotic challenges were monitored as an index of relative cell volume change with an Olympus X51 microscope. Readings were taken every 30 s for 10 min. The total calcein fluorescence intensity was measured by Universal Imaging MetaMorph software. The cross-sectional area was assumed to be proportional to the cell volume and was expressed as a relative value to control conditions (t ! 0 s). Relative volume ( V t / V 0 ) was calculated as (
, where V t is the cell volume at time t and V 0 is the initial cell volume. F 0 is the fluorescence of cells in isotonic solution and F t is the fluorescence intensity at time t. f b is the background fluorescence. Data are presented as means 8 SD. Significant differences between individual groups were tested by using analysis of variance. Cell volume was first measured in isotonic solutions and then in the following: hypotonic solutions, Ca 2+ -free hypotonic solutions and hypotonic solutions containing Gd 3+ . Hanks' balanced salt solution was used as an isotonic solution. Hypotonicity was achieved by the addition of distilled water, lowering the osmolarity from 300 mosm to 200 mosm. GdCl 3 (Sigma, Japan) was used at a final concentration of 100 M prepared in Hanks' balanced salt solution. Modified Hanks' balanced salt solution (138 m M NaCl, 5 m M KCl, 0.5 m M MgCl 2 , 1.0 m M EGTA, 5 m M glucose, 10 m M HEPES, pH 7.2) was used for Ca 2+ -free experiments. Measurements of cell volume changes were performed in both the mitochondria-rich cells and the ribosomerich cells. The cells measured were considered to be mitochondria rich if they were round and ribosome rich if they were polygonal [Qvortrup et al., 1994; Kumagami et al., 1998 ].
Human Endolymphatic Sac
Samples of endolymphatic sac tissue were obtained during endolymphatic sac surgery from 6 patients who had undergone a translabyrinthine removal of a vestibular schwannoma and 6 patients with Ménière's disease.
Patient Data: Vestibular Schwannoma Patients
The 6 patients with vestibular schwannoma ranged in age from 34 to 62 years, and had a mean age of 48.8 years. All the patients with vestibular schwannoma were unilaterally affected and pure-tone audiometry showed they had sensorineural hearing loss in their affected ears that ranged from 60 dB to total deafness, with an average of 76.5 dB. The diameters of their tumors were all within 3.0 cm and the histopathological diagnosis was schwannoma in all 6 cases.
Patient Data: Ménière's Disease Patients
All 6 patients with Ménière's disease had definite cases that were diagnosed in accordance with the diagnostic scale for Mé-nière's disease from the American Academy of OtolaryngologyHead and Neck Surgery [1995] . The age of the patients in this group ranged from 32 to 49 years, with an average of 39.3 years. The duration of the disease ranged from 2 to 4 years, with an average of 2.6 years. All the patients were unilaterally affected, showing sensorineural hearing loss in their affected ears and intractable vertigo attacks.
Specimen Collection
In the patients with vestibular schwannoma, almost all the intraosseous portion of the endolymphatic sac was excised. In the patients with Ménière's disease, a part of the intermediate portion of the endolymphatic sac was biopsied. The purpose of the study was explained to each patient, and informed consent was obtained before the surgeries. All procedures were performed in accordance with the guidelines of the Declaration of Helsinki.
Tissue Preparation for Immunohistochemistry in the Human Endolymphatic Sac
Immediately after removal, the endolymphatic sac was washed with saline to remove blood and bone dust. The samples ranged in length from 2 to 3 mm. The specimens were shock frozen in liquid-nitrogen-cooled isopentane and were stored at -70 ° C. Cryostat sections 4 m thick were made. The sections were then serially sectioned as parallel as possible to the long axis of the endolymphatic sac, fixed and mounted on a glass slide. 
Immunostaining Procedure for the Human Endolymphatic Sac
Sections were immersed in 1.5% Triton X-100 in PBS at pH 7.2 for 5 min, followed by immersion in 3% H 2 O 2 for 5 min, and they were then blocked with 5% normal goat serum in PBS for 1 h. We used a polyclonal TRPV4 that was originally raised against a synthetic peptide representing the carboxyl-terminal sequence of TRPV4. The antibody was subjected to affinity purification with the peptide antigen (CDG HQQ GYA PKW RTD DAP L). The specimens were incubated overnight in a humidified chamber at 4 ° C with the antibody at a dilution of 1: 200 in PBS. Then, the sections were incubated overnight in a humidified chamber at 4 ° C with the first antibody at a dilution of 1: 200 in PBS, washed 3 times with 0.0075% Bruji 35 in PBS, and reacted with horseradish peroxidase goat anti-rabbit immunoglobulin G for 1 h. After the slides had been washed with 0.0075% Briji 35 in PBS, horseradish peroxidase sites were visualized with 3,3 -diaminobenzine-4HCl (DAB)/H 2 O 2. For negative controls, normal rabbit immunoglobulin G or normal rabbit serum was used instead of the first antibody in every experiment. For laser microscopic imaging, the same procedure was employed as for the rat endolymphatic sac.
Results
Tissue Culture of the Rat Endolymphatic Sac
Outgrowth of epithelial-like cells of the explant was observed in culture. In culture, ribosome-rich cells had a flat polygon shape, whereas cells corresponding to mitochondria-rich cells were round. The 2 cell types could be easily distinguished by shape and surface morphology by a differential interference contrast infrared light microscopy ( fig. 1 a-c) . In the tissue culture of the rat endolymphatic sac, the basic ultrastructures of the epithelium were preserved well. The shapes of the cells were observed by scanning electron microscopy ( fig. 2 a, b) .
Immunostaining of TRPV4 of the Rat Endolymphatic Sac in Culture
Moderate-to-strong staining of TRPV4 was observed in both the ribosome-rich cells and the mitochondriarich cells; however, strong staining of TRPV4 was predominantly observed in the apical membrane of the mitochondria-rich cells ( fig. 3 a-c) .
Cell Volume Measurement
Although strong staining of TRPV4 was more dominant in the mitochondria-rich cells than in the ribosomerich ones, cell volume measurements were performed in both types. Reduction of extracellular osmolarity led to a rapid increase in the volume of round-shaped cells, which were recognized as mitochondria-rich cells, followed by a regulatory volume decrease. The mitochondria-rich cells in culture reached a maximum volume of 25-35% above that of control cells in isotonic conditions. A decrease in cell volume by regulatory processes started about 180 s after exposure to hypotonic solutions. After 360 s, 90% of the observed cells had completed their regulatory volume decrease and most of them had regained their original volume. Replacement of the medium alone did not affect cell volume; however, treatment with 100-M Gd 3+ solution blocked regulatory volume decrease, and no subsequent regulatory volume decrease occurred after the initial swelling in Ca 2+ -free solutions ( fig. 4 ). In the ribosome-rich cells, regulatory volume decrease in hypotonic solutions was observed to be the same as that seen in the mitochondria-rich cells. However, among ribosome-rich cells, cells showing a weak inhibition of their regulatory volume decrease in Gd 3+ and Ca 2+ -free hypotonic solutions coexisted with cells showing no inhibition of regulatory volume decrease ( fig. 5 ) . Thus, compared to the result for the mitochondria-rich cells, the ribosome-rich cells showed a lesser inhibition of cell volume decrease by 100 M Gd 3+ or Ca 2+ -free solution, on average. 
Immunostaining of TRPV4 of the Endolymphatic Sac in Humans
Moderate-to-strong staining of TRPV4 in the epithelium of the endolymphatic sac obtained from all 6 patients with vestibular schwannoma was demonstrated by light-microscopic observations ( fig. 6 a) . No degeneration of the endolymphatic sac epithelium was observed in the 6 patients with vestibular schwannoma. Regarding Mé-nière's disease, in 2 patients whose epithelial cells were well preserved, TRPV4 was observed in the epithelium ( fig. 6 b) . However, in 4 cases, it was difficult to determine whether the epithelium of the endolymphatic sac had degenerated or whether it had not been adequately obtained and fixed ( fig. 6 c) . In the kidney tissue of rats selected as control specimens, positive staining was demonstrated, and staining without the primer antibody was negative.
Discussion
Our results indicate that TRPV4 has a functional role as an osmosensor in the endolymphatic sac. TRPV4 expression in the rat endolymphatic sac is more dominant in the apical membrane of the mitochondria-rich cells than in the ribosome-rich cells. The mitochondria-rich cells protrude into the lumen of the endolymphatic sac and the apical membrane faces the endolymph. Based on this, in the endolymphatic sac TRPV4 should be used by the mitochondria-rich cells to sense an osmotic gradient in the endolymph.
In the human keratinocyte cell line (HaCaT) that produces TRPV4 endogenously, during swelling and volume regulation a strong Ca 2+ influx is measured, regulatory volume decrease is blocked by Gd 3+ and is diminished in a Ca 2+ -free solution [Becker et al., 2005] . Since Gd 3+ has been described as an inhibitor of TRPV4 [Becker et al., 2005] as well as the stretch-activated channel [Caldwell et al., 1998 ], Gd 3+ was used to inhibit TRPV4 in the present study. In the endolymphatic sac, regulatory volume decrease of mitochondria rich-cells is clearly inhibited by Gd 3+ at all measurements. Thus, TRPV4 would be a likely candidate for mediating regulatory volume decrease in the mitochondria-rich cells. Since the mitochondria-rich cells in the endolymphatic sac are suggested to have several ion channels and transporters, such as pendrin or vascular H + -ATPase [Peters et al., 2002; Dou et al., 2004] , they may play an important role in ion and pH regulation of the endolymph. In addition to the above ion channels and pumps, it is assumed that mitochondria-rich cells maintain proper cell functioning using TRPV4 to respond to osmolarity changes and to regulate cell volume.
In contrast, regulatory volume decrease is not always inhibited by Gd 3+ in ribosome-rich cells. Immunostaining shows that TRPV4 is predominantly present in mitochondria-rich cells, and thus it seems to function con stitutively. However, TRPV4 is not present in all ribosome-rich cells, and so in these cells it is assumed to be conditionally expressed and to exhibit a functional role. These TRPV4 expression patterns are similar to those seen in the rat kidney collecting duct, where intercalated cells that have abun- dant mitochondria exhibit greater TRPV4 expression than principal cells with abundant ribosomes absorbing water [Tian et al., 2004; Cohen, 2005] .
As regulatory volume decrease was inhibited in a Ca 2+ -free solution, it appears that Ca 2+ also plays an important role in cell volume regulation associated with TRPV4 in the endolymphatic sac. In the present study, regulatory volume decrease of cells in the endolymphatic sac, especially mitochondria-rich cells, were inhibited by Ca 2+ -free solutions. Although cytosolic Ca 2+ of the endolymphatic sac epithelium was not measured, the influx of Ca 2+ accompanied by activation of TRPV4 in hypotonicity would seem to be essential for regulatory volume decrease in the endolymphatic sac epithelium expressing TRPV4.
Our study revealed a physiological role of TRPV4 in the rat endolymphatic sac, and also the presence of TRPV4 in the human endolymphatic sac. TRPV4 is also involved in the synthesis of vasopressin [Mizuno et al., 2003] , secretion [Liu et al., 2006] , fluid viscosity changes and ciliary function [Andrade et al., 2005] . In the human endolymphatic sac, hyaluronan ] is synthesized and natriuretic peptide receptors are present [Dornhoffer et al., 2002] , and in the rat endolymphatic sac, natriuretic peptide production has been suggested to occur [Qvortrup et al., 1996] . Since TRPV4 exhibits a functional role in the reactions of the endolymphatic epithelium to changes in osmolality, TRPV4 may participate in the synthesis of hyaluronan and natriuretic peptide, which are related to osmoregulation. This should be further investigated.
In the present study, we observed staining of TRPV4 in the endolymphatic sacs of patients with Ménière's disease, which suggests the ion channel plays a role in this disease. Regarding the pathological findings in the endolymphatic sac of patients with Ménière's disease, Hebbar et al. [1991] reported that the sac was of small size, Schindler et al. [1979] found perisaccular fibrosis, Schindler et al. [1979] and Kumagami [1990] reported degeneration of the epithelium and Danckwardt-Lillieström et al. [1994] observed saccitis. However, our knowl- Moderate-to-strong staining in the epithelium of the endolymphatic sac can be seen. In this case, the epithelium was preserved. c A confocal laser microscopic observation of immunofluorescence staining of TRPV4 in the endolymphatic sac obtained from a patient with Ménière's disease. The confocal laser microscopic image is combined with differential interference contrast imaging. Although immunofluorescence of TRPV4 seems to be limited in the remaining epithelium, it is difficult to determine whether the epithelium of the endolymphatic sac has degenerated or was not adequately obtained and fixed.
edge of the ultrastructure of well-preserved human endolymphatic sac is still limited [Lim and Glasscock, 1981; Danckwardt-Lillieström et al., 2000] and findings in the endolymphatic sacs of Ménière's disease patients remain controversial [Wackym et al., 1990] . In the present study, as the sample size was small and the number of well-preserved endolymphatic sacs obtained from patients with Ménière's disease was limited, it was difficult to distinguish degeneration from a traumatized piece of the endolymphatic sac. Thus, we could not reach a conclusion on the essential roles of TRPV4 in Ménière's disease. Therefore, further studies analyzing human endolymphatic specimens adequately obtained from patients with Mé-nière's disease are required.
